Manpower Software appoints Allen Swann

Manpower Software, a leading provider of workforce optimisation solutions, is pleased to announce it has appointed Allen Swann to serve as Business Development Director and a member of the Board of Directors with immediate effect.

Allen Swann commented:

“I am very pleased to be offered this opportunity to join the Board of Directors.  My association with the company over the past 2.5 years has highlighted how important a role Manpower Software is playing in helping the UK Healthcare market more effectively utilise its staff, reduce costs, improve patient care and improve working lives. 

“There is an immense opportunity for the company to continue to make a difference.”

Mr Swann first became associated with the Manpower Software during February 2006 whilst acting as Interim Sales Director. 

Since May 2007, he has focussed on building a substantial presence in the UK Healthcare Market. 

Mr Swann is also Non Executive Chairman of the Board of CopperEye, a privately funded UK software company majoring in the telco marketplace, and a Non Executive Director of Chordiant Software, a US based software company, which provides CRM software platforms to the world’s largest financial institutions. 

Prior to these appointments he served as International President for Chordiant Software, International President of Prime Response and was a founder member of Oracle UK, where he served as Sales Director both direct and non-direct for 12 years.

Commenting on the announcement, Terry Osbourne, Manpower Software’s Chairman, commented:

“We are both fortunate and delighted that Allen, with his 25 years experience of the global software industry, will join us to provide strong business development leadership and execution skills at this critical stage in the company’s development. 

“His multi-national, multi-disciplined management abilities will be invaluable as the company builds its sales and services capabilities to create profitable operations across multiple sectors and continents.”

Comments are closed.